All
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Search
Notebook
Report an inappropriate content
Please select one of the options below.
Not Relevant
Offensive
Adult
Child Sexual Abuse
Length
All
Short (less than 5 minutes)
Medium (5-20 minutes)
Long (more than 20 minutes)
Date
All
Past 24 hours
Past week
Past month
Past year
Resolution
All
Lower than 360p
360p or higher
480p or higher
720p or higher
1080p or higher
Source
All
Dailymotion
Vimeo
Metacafe
Hulu
VEVO
Myspace
MTV
CBS
Fox
CNN
MSN
Price
All
Free
Paid
Clear filters
SafeSearch:
Moderate
Strict
Moderate (default)
Off
Filter
Evolving Role of Trastuzumab Deruxtecan in HER2 /HER2-Low m
…
Jan 11, 2020
onclive.com
Trastuzumab Cardiotoxicity in mBC: When to Restart HER2 Therapy?
…
49 views
May 28, 2023
vumedi.com
Trastuzumab deruxtecan versus trastuzumab emtansine in patient
…
Dec 22, 2022
onclive.com
Dr. Esteva on Clinical Trial Design of Trastuzumab Biosimilar in HER
…
Sep 7, 2016
onclive.com
SABCS 2023 Insights: "HER2CLIMB-02 Trial of Tucatini
…
337 views
Dec 13, 2023
vumedi.com
Trastuzumab Deruxtecan for Patients With HER2 Metastatic Br
…
Nov 2, 2023
onclive.com
FDA Approves First Targeted Drug To Treat HER2-Low Breast Cancer
…
Aug 5, 2022
mskcc.org
Dr. Messersmith on the Potential for Trastuzumab Deruxtecan in HER2
…
May 12, 2021
onclive.com
Dr. Basho on the Integration of Trastuzumab Deruxtecan in HER2
…
Jul 22, 2021
onclive.com
Dr. Vidal on Potential of [Fam-] Trastuzumab Deruxtecan in HER2
…
Nov 15, 2019
onclive.com
Subcutaneous vs Intravenous Pertuzumab/Trastuzumab for Trea
…
Jan 30, 2023
onclive.com
Dr. Tkaczuk on the Utilization of Trastuzumab Deruxtecan in HER2
…
Oct 5, 2022
onclive.com
SABCS 2023 Insights: "HER2CLIMB-05 Trial - Tucatinib
…
258 views
Dec 20, 2023
vumedi.com
Dr. Hope Rugo on Safety of Trastuzumab Biosimilar for HER2
…
Oct 14, 2016
onclive.com
Dr. Extermann on the Utility of Trastuzumab Monotherapy in HER
…
Aug 11, 2021
onclive.com
Dr. Hurvitz on FDA Approval of Subcutaneous Trastuzumab Form
…
Mar 9, 2019
onclive.com
HER2CLIMB-02: Randomized, Double-blind Phase 3 Trial of Tuc
…
Feb 5, 2024
onclive.com
Rapid Readout: Updated results of tucatinib vs placebo added to tras
…
Dec 22, 2021
onclive.com
11:33
HER2CLIMB-02: Primary Analysis of a Randomized, Double-blind Phas
…
Jan 25, 2024
onclive.com
1:41
The HER Signaling Pathway
55.6K views
Nov 13, 2012
YouTube
Genentech
11:07
Treatment of HER2-Positive Breast Cancer
8.1K views
Jul 1, 2015
YouTube
OncLive
7:39
Preventing Recurrence: HER2-positive Breast Cancer
18.8K views
Jan 11, 2018
YouTube
curetoday
3:04
Trastuzumab Deruxtecan for HER2+ Breast Cancer
7.7K views
Mar 27, 2018
YouTube
OncLive
14:08
HER2 Amplification and Breast Cancer Part 1
24.4K views
Nov 10, 2014
YouTube
Elliot Nicholson
8:49
Case Study: Treating HER2-Positive Metastatic Breast Cancer, Part I
3.7K views
Aug 14, 2013
YouTube
OncLive
1:06
Immunotherapy Combination in HER2-Positive Breast Cancer
731 views
Aug 2, 2018
YouTube
Targeted Oncology
8:42
Trastuzumab Deruxtecan in HER2+ Breast Cancer
443 views
Jul 7, 2020
YouTube
Targeted Oncology
19:38
Medical Update: HER2-Positive Metastatic Breast Cancer
11.9K views
Jul 15, 2020
YouTube
Living Beyond Breast Cancer
4:47
Using your Invitrogen ELISA kit
139.5K views
Oct 4, 2018
YouTube
Thermo Fisher Scientific
7:41
HER2-Targeted Therapy in Early Stage HER2+ Breast Cancer
4.9K views
Mar 3, 2017
YouTube
OncLive
See more videos
More like this
Feedback
Feedback